The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

skilled trades mentorship
Why the Modern Data Center Is Forcing Communities and Policymakers to Rethink Infrastructure
April 21, 2026

Data centers have moved from largely invisible digital infrastructure to a highly visible source of public debate as artificial intelligence accelerates demand for power, fiber, and compute capacity. The modern data center is now being built closer to population centers to support low-latency services, bringing critical infrastructure into direct contact with residential communities for…

Read More
Inside the Spot Freight Shift: How Manifold Is Simplifying a Fragmented Logistics Market
April 21, 2026

The freight market is in the midst of a notable shift. With national tender rejection rates approaching 14% by the end of Q1, freight conditions have shifted back in carriers’ favor, often coinciding with increased activity in the spot market. At the same time, logistics teams are juggling an increasingly fragmented ecosystem of portals, emails,…

Read More
healthcare 2026
Healthcare’s 2026 Reality: Growing Workforce Gaps, Tiered Access, and the Rise of AI Support
April 20, 2026

Healthcare systems are entering 2026 under mounting pressure. A growing, aging population and rising disease burden are colliding with persistent workforce shortages—highlighted by projections that new cancer diagnoses in the U.S. will surpass two million this year alone. The stakes are no longer theoretical: delays in care, limited specialist access, and widening disparities are…

Read More
Mental Health Care
Policy, AI, and New Funding Models Are Reshaping Mental Health Care Delivery
April 16, 2026

Mental health care isn’t a new problem—but it’s finally being treated like an urgent one. After years of being sidelined, the cracks in the system are becoming impossible to ignore: overstretched clinicians, long wait times, and entire communities without consistent access to care. In the U.S., the scale is striking—more than one in five…

Read More